Trustmark (TRMK) reported $205.15 million in revenue for the quarter ended September 2025, representing a year-over-year increase of 4.9%. EPS of $0.94 for the same period compares to $0.84 a year ago.
The reported revenue represents a surprise of -0.51% over the Zacks Consensus Estimate of $206.2 million. With the consensus EPS estimate being $0.95, the EPS surprise was -1.05%.
While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to Wall Street expectations to determine their next course of action, some key metrics always provide a better insight into a company's underlying performance.
As these metrics influence top- and bottom-line performance, comparing them to the year-ago numbers and what analysts estimated helps investors project a stock's price performance more accurately.
Here is how Trustmark performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:
- Net Interest Margin: 3.8% versus 3.8% estimated by three analysts on average.
- Efficiency Ratio: 62% compared to the 61.9% average estimate based on three analysts.
- Net (recoveries) charge-offs / average loans: 0.1% versus the two-analyst average estimate of 0.2%.
- Total nonaccrual LHFI: $83.96 million compared to the $79.91 million average estimate based on two analysts.
- Total nonperforming assets: $92.28 million versus the two-analyst average estimate of $89.28 million.
- Average Balances - Total earning assets: $17.11 billion compared to the $17.25 billion average estimate based on two analysts.
- Net Interest Income: $162.44 million versus $163.92 million estimated by three analysts on average.
- Total Noninterest income: $39.93 million compared to the $40.48 million average estimate based on three analysts.
- Net Interest Income (FTE): $165.22 million versus $166.24 million estimated by two analysts on average.
View all Key Company Metrics for Trustmark here>>>
Shares of Trustmark have returned -2.6% over the past month versus the Zacks S&P 500 composite's +3.6% change. The stock currently has a Zacks Rank #4 (Sell), indicating that it could underperform the broader market in the near term.
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Trustmark Corporation (TRMK): Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).
Zacks Investment Research
